Statera Biopharma, Inc. 8-K SEC Filings

Filed On	Filing
01 Feb 2023	8-K: Material Modification to Rights of Security Holders; Amendments to Articles/Bylaws; Change in Fiscal Year
20 Jan 2023	8-K: Notice of Delisting or Failure to Satisfy a Listing Rule
15 Nov 2022	8-K: Entry into a Material Definitive Agreement; Creation of a Direct Financial Obligation +1 more
07 Nov 2022	8-K: Entry into a Material Definitive Agreement; Unregistered Sales of Equity Securities
27 Oct 2022	8-K: Other Events
24 Oct 2022	8-K: Entry into a Material Definitive Agreement; Creation of a Direct Financial Obligation +2 more
17 Oct 2022	8-K: Entry into a Material Definitive Agreement; Notice of Delisting or Failure to Satisfy a Listing Rule
27 Sep 2022	8-K: Notice of Delisting or Failure to Satisfy a Listing Rule
09 Sep 2022	8-K: Entry into a Material Definitive Agreement; Notice of Delisting or Failure to Satisfy a Listing Rule +2 more
03 Aug 2022	8-K: Changes in Registrant's Certifying Accountant; Regulation FD Disclosure
22 Jun 2022	8-K: Departure/Election of Directors or Officers; Compensation
06 Jun 2022	8-K: Departure/Election of Directors or Officers; Compensation
27 May 2022	8-K: Entry into a Material Definitive Agreement; Triggering Events That Accelerate a Financial Obligation +2 more
27 Apr 2022	8-K: Departure/Election of Directors or Officers; Compensation
18 Apr 2022	8-K: Other Events
15 Apr 2022	8-K: Changes in Registrant's Certifying Accountant
31 Mar 2022	8-K: Triggering Events That Accelerate a Financial Obligation; Notice of Delisting or Failure to Satisfy a Listing Rule +1 more
25 Mar 2022	8-K: Entry into a Material Definitive Agreement; Regulation FD Disclosure
25 Mar 2022	8-K: Notice of Delisting or Failure to Satisfy a Listing Rule
22 Mar 2022	8-K: Entry into a Material Definitive Agreement

Comments